In a statement to the EGX, Cleopatra Hospitals (CLHO) board of directors (BoD) stated that the decision to sell a stake in the company is up to CLHO’s shareholders.
Sounds Familiar?🧐 A similar situation happened with SODIC recently, after its BoD released a statement to the EGX stating that the decision ultimately rests in the shareholders’ hands.
Why is this Important🤔 CLHO BoD revealed that the EGP 5/share offer is 14% higher than the average trading price CLHO in the past six months, & 12% higher than the average closing price of CLHO in the last three months.
CLHO shareholders have six more days to respond to the offer.